U.S. Markets close in 1 hr 51 mins
  • S&P 500

    3,642.78
    +13.13 (+0.36%)
     
  • Dow 30

    29,937.62
    +65.15 (+0.22%)
     
  • Nasdaq

    12,230.34
    +135.93 (+1.12%)
     
  • Russell 2000

    1,845.68
    +0.65 (+0.04%)
     
  • Crude Oil

    45.41
    -0.30 (-0.66%)
     
  • Gold

    1,784.80
    -26.40 (-1.46%)
     
  • Silver

    22.73
    -0.72 (-3.05%)
     
  • EUR/USD

    1.1957
    +0.0044 (+0.3707%)
     
  • 10-Yr Bond

    0.8570
    -0.0210 (-2.39%)
     
  • Vix

    20.82
    -0.43 (-2.02%)
     
  • GBP/USD

    1.3349
    -0.0008 (-0.0574%)
     
  • USD/JPY

    103.9850
    -0.2650 (-0.2542%)
     
  • BTC-USD

    16,638.11
    -528.54 (-3.08%)
     
  • CMC Crypto 200

    325.47
    -12.03 (-3.56%)
     
  • FTSE 100

    6,359.67
    -3.26 (-0.05%)
     
  • Nikkei 225

    26,644.71
    +107.40 (+0.40%)
     

Atara Biotherapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 27, 2020 / Atara Biotherapeutics, Inc. (ATRA) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 27, 2020 at 8:00 AM Eastern Time.

To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/event/presentation/59923

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network



View source version on accesswire.com:
https://www.accesswire.com/578027/Atara-Biotherapeutics-Inc-to-Host-Earnings-Call